Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation

Geoffrey D Barnes, Walter Ageno, Lana A Castellucci, Thita Chiasakul, Renee Eslick, Jose Luis Ferreiro, David Gailani, Diana Gorog, Gregory Y H Lip, Leslie Raffini, Suely M Rezende, Jeffrey I Weitz, Adam Cuker

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)

Abstract

Oral anticoagulation therapy has evolved beyond vitamin K antagonists to include oral direct thrombin inhibitors and factor Xa inhibitors. Collectively known as “direct oral anticoagulants,” this class of medications represents the current standard of care for the prevention and treatment of common thrombotic disorders, including atrial fibrillation and venous thromboembolism. Medications that target factors XI/XIa and XII/XIIa are currently under investigation for several thrombotic and nonthrombotic conditions. Given that these emerging medications will likely have distinct risk-benefit profiles to the current direct oral anticoagulants, may have different routes of administration, and could be used for unique clinical conditions (e.g., hereditary angioedema), the International Society on Thrombosis and Haemostasis Subcommittee on Control of Anticoagulation assembled a writing group to make recommendations on the nomenclature of anticoagulant medications. With input from the broader thrombosis community, the writing group recommends that anticoagulant medications be described by the route of administration and specific targets (e.g., oral factor XIa inhibitor).

Original languageEnglish
Pages (from-to)1381-1384
Number of pages4
JournalJournal of Thrombosis and Haemostasis (JTH)
Volume21
Issue number5
Early online date14 Feb 2023
DOIs
Publication statusPublished - 30 May 2023

Keywords

  • anticoagulant
  • atrial fibrillation
  • factor XII
  • factor XIa
  • factor Xa inhibitors
  • venous thromboembolism

Fingerprint

Dive into the research topics of 'Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation'. Together they form a unique fingerprint.

Cite this